Recombinant Anti-DLL4 x Anti-VEGF Bispecific Antibody (Tandem scFv-Fc) is designed to be expressed as a homodimer, which has 2+2 antigen-binding valency. This format consists of one Fc region and two tandem scFv fragments, in which the anti-DLL4/VEGF tandem scFv is fused to the Fc domain. The engineered fragment format is used to extend the half-life. This BsAb can bind and inactivate two ligands simultaneously. It is designed for the research of Solid tumors therapy.